English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

The developmental expression of vasoactive intestinal peptide (VIP) in cholinergic sympathetic neurons depends on cytokines signaling through LIFR β-containing receptors

MPS-Authors
/persons/resource/persons207934

Duong,  C. V.
Neurochemistry Department, Max Planck Institute for Brain Research, Max Planck Society;

/persons/resource/persons207969

Geissen,  M.
Neurochemistry Department, Max Planck Institute for Brain Research, Max Planck Society;

/persons/resource/persons208168

Rohrer,  H.
Developmental Neurobiology Group, Max Planck Institute for Brain Research, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Duong, C. V., Geissen, M., & Rohrer, H. (2002). The developmental expression of vasoactive intestinal peptide (VIP) in cholinergic sympathetic neurons depends on cytokines signaling through LIFR β-containing receptors. Development, 129(6), 1387-1396.


Cite as: http://hdl.handle.net/11858/00-001M-0000-002E-1C34-0
Abstract
Sympathetic ganglia are composed of noradrenergic and cholinergic neurons. Cholinergic sympathetic neurons are characterized by the expression of choline acetyl transferase (ChAT), vesicular acetylcholine transporter (VAChT) and the vasoactive intestinal peptide (VIP). To investigate the role of cytokine growth factor family members in the development of cholinergic sympathetic neurons, we interfered in vivo with the function of the subclass of cytokine receptors that contains LIFRbeta as essential receptor subunit. Expression of LIFRbeta antisense RNA interfered with LIFRbeta expression and strongly reduced the developmental induction of VIP expression. By contrast, ganglion size and the number of ChAT-positive cells were not reduced. These results demonstrate a physiological role of cytokines acting through LIFRbeta-containing receptors in the control of VIP expression in sympathetic neurons.